SS
Salim Syed Mizuho Latest Price Targets & Analyst Ratings
Main Sector
Healthcare
Ratings Past Year
8
Avg Return
Past Year
Past Year
28%
Success Rate
Past Year
Past Year
0
%
Rating Distribution
Past Year
Positive
87.5%
Neutral
12.5%
Negative
0%
Past Week
Past Month
Past 3 Months
Past 6 Months
Past Year
All Time
Positive
Neutral
Negative
Large Cap
$10B to $200B
Mid Cap
$2B to $10B
Small Cap
$250M to $2B
Micro Cap
Under $250M
Healthcare
Healthcare
Biotechnology
Drug Manufacturers - General
| Stock | Rating | Price Target |
Upside Downside |
Ratings 1 Year |
Avg Return 1 Year |
Success Rate 1 Year | Date | |
|---|---|---|---|---|---|---|---|---|
|
Outperform
Initiated
| $97 |
276%
upside
| 1 | +14% |
0
%
| 10 Mar ‘26 1 month ago |
|
|
|
Outperform
Upgraded
| $121 |
28%
upside
| 1 | -9.1% |
0
%
| 8 Dec ‘25 4 months ago |
|
|
|
Outperform
Maintained
| $40 |
44%
upside
| 1 | -23% |
0
%
| 20 Nov ‘25 5 months ago |
|
|
|
Outperform
Maintained
| $14 |
379%
upside
| 1 | +24% |
0
%
| 10 Jun ‘25 10 months ago |
|
|
|
Outperform
Maintained
| $84 |
29%
upside
| 1 | +96% |
0
%
| 29 May ‘25 11 months ago |
|
|
|
Outperform
Maintained
| $169 |
8%
downside
| 1 | +58% |
0
%
| 7 May ‘25 11 months ago |
|
|
|
Neutral
Maintained
| $280 |
19%
downside
| 1 | – |
–
| 7 May ‘25 11 months ago |
|
|
|
Outperform
Maintained
| $117 |
10%
downside
| 1 | +40% |
0
%
| 5 May ‘25 11 months ago |
|